CIK: 0001425738 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: Feb 16, 2016
Total Value ($000): $1,336,352 (99.7% shares, 0.3% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS INC | 10,280,620 | $99,722 | 7.5% | $7.20 | +25.2% | COM | 03152W109 |
| — | MEDIVATION INC | 1,599,393 | $77,315 | 5.8% | $42.50 | — | COM | 58501N101 |
| PEN | PENUMBRA INC | 1,537,570 | $76,213 | 5.7% | $40.45 | +12.0% | COM | 70975L107 |
| — | ARRAY BIOPHARMA INC | 17,850,650 | $75,330 | 5.6% | $4.95 | — | COM | 04269X105 |
| — | INTRA CELLULAR THERAPIES INC | 1,223,717 | $65,824 | 4.9% | $29.91 | — | COM | 46116X101 |
| — | CLOVIS ONCOLOGY INC | 1,795,936 | $62,858 | 4.7% | $45.27 | — | COM | 189464100 |
| — | SEATTLE GENETICS INC | 1,372,492 | $61,597 | 4.6% | $36.43 | — | COM | 812578102 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 938,139 | $61,579 | 4.6% | $61.11 | — | ADR | 881624209 |
| — | SAGE THERAPEUTICS INC | 958,374 | $55,873 | 4.2% | $50.11 | — | COM | 78667J108 |
| — | PORTOLA PHARMACEUTICALS INC | 958,155 | $49,297 | 3.7% | $44.82 | — | COM | 737010108 |
| — | WELLCARE HEALTH PLANS INC | 562,873 | $44,022 | 3.3% | $85.49 | — | COM | 94946T106 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 3,671,344 | $42,551 | 3.2% | $9.65 | +0.2% | COM CL A | 46333X108 |
| BSX | BOSTON SCIENTIFIC CORP | 2,251,020 | $41,509 | 3.1% | $17.92 | 0.0% | COM | 101137107 |
| — | PFIZER INC | 1,260,400 | $40,686 | 3.0% | — | — | Call | 717081903 |
| — | ATARA BIOTHERAPEUTICS INC | 1,534,962 | $40,538 | 3.0% | $30.53 | — | COM | 046513107 |
| INCY | INCYTE CORP | 357,912 | $38,816 | 2.9% | $109.81 | +1.6% | COM | 45337C102 |
| — | DIPLOMAT PHARMACY INC | 1,115,902 | $38,186 | 2.9% | $34.22 | — | COM | 25456K101 |
| — | NEVRO CORP | 415,198 | $28,030 | 2.1% | $66.24 | — | COM | 64157F103 |
| — | NEURODERM LTD | 1,589,261 | $27,097 | 2.0% | $20.38 | — | ORD SHS | M74231107 |
| CNC | CENTENE CORP DEL | 408,000 | $26,850 | 2.0% | $33.46 | -11.5% | COM | 15135B101 |
| INSM | INSMED INC | 1,391,813 | $25,261 | 1.9% | $16.89 | +4.3% | COM PAR $.01 | 457669307 |
| UNH | UNITEDHEALTH GROUP INC | 187,034 | $22,003 | 1.6% | $99.29 | 0.0% | COM | 91324P102 |
| — | ALLERGAN PLC | 68,758 | $21,487 | 1.6% | $312.50 | — | SHS | G0177J108 |
| — | MODEL N INC | 1,868,159 | $20,849 | 1.6% | $10.67 | — | COM | 607525102 |
| — | ZELTIQ AESTHETICS INC | 709,426 | $20,240 | 1.5% | $28.53 | — | COM | 98933Q108 |
| — | NANOSTRING TECHNOLOGIES INC | 1,357,692 | $19,972 | 1.5% | $13.36 | — | COM | 63009R109 |
| WVE | WAVE LIFE SCIENCES LTD | 1,213,627 | $18,326 | 1.4% | $15.68 | 0.0% | SHS | Y95308105 |
| CTMX | CYTOMX THERAPEUTICS INC | 738,356 | $14,405 | 1.1% | $15.82 | 0.0% | COM | 23284F105 |
| — | HEALTH NET INC | 181,029 | $12,393 | 0.9% | $51.74 | — | COM | 42222G108 |
| — | ENDOLOGIX INC | 1,007,177 | $9,971 | 0.7% | $9.90 | — | COM | 29266S106 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 860,288 | $9,893 | 0.7% | $17.17 | — | ORD SHS | G6855A103 |
| CRL | CHARLES RIV LABS INTL INC | 122,400 | $9,840 | 0.7% | $72.12 | 0.0% | COM | 159864107 |
| — | TRIVASCULAR TECHNOLOGIES INC | 1,462,762 | $9,727 | 0.7% | $14.40 | — | COM | 89685A102 |
| FATE | FATE THERAPEUTICS INC | 2,371,001 | $7,990 | 0.6% | $5.78 | -27.3% | COM | 31189P102 |
| — | PRESS GANEY HLDGS INC | 239,616 | $7,560 | 0.6% | $30.85 | — | COM | 74113L102 |
| — | BLUEPRINT MEDICINES CORP | 276,687 | $7,288 | 0.5% | $25.57 | — | COM | 09627Y109 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 218,718 | $7,071 | 0.5% | $42.16 | — | COM | 37890U108 |
| — | DURECT CORP | 2,628,416 | $5,809 | 0.4% | $1.95 | — | COM | 266605104 |
| — | INVITAE CORP | 660,129 | $5,420 | 0.4% | $9.07 | — | COM | 46185L103 |
| — | ONCOTHYREON INC | 2,331,300 | $5,175 | 0.4% | $3.74 | — | COM | 682324108 |
| PRQR | PROQR THRAPEUTICS N V | 557,193 | $4,836 | 0.4% | $16.18 | -28.9% | SHS EURO | N71542109 |
| PFE | PFIZER INC | 123,800 | $3,996 | 0.3% | $20.38 | 0.0% | COM | 717081103 |
| — | ARRAY BIOPHARMA INC | 4,000,000 | $3,702 | 0.3% | $1.09 | — | NOTE 3.000% 6/0 | 04269XAA3 |
| — | ELEVEN BIOTHERAPEUTICS INC | 875,857 | $2,636 | 0.2% | $4.50 | — | COM | 286221106 |
| — | CONFORMIS INC | 125,709 | $2,174 | 0.2% | $18.06 | — | COM | 20717E101 |
| — | CELGENE CORP | 10,055 | $1,204 | 0.1% | $119.74 | — | COM | 151020104 |
| IHF | ISHARES TR | 4,520 | $562 | 0.0% | $124.34 | — | US HLTHCR PR ETF | 464288828 |
| — | CHEMOCENTRYX INC | 63,189 | $512 | 0.0% | $8.10 | — | COM | 16383L106 |
| — | PRONAI THERAPEUTICS INC | 24,787 | $373 | 0.0% | $19.09 | — | COM | 74346L101 |
| LAB | FLUIDIGM CORP DEL | 32,561 | $352 | 0.0% | $25.55 | -61.6% | COM | 34385P108 |
| XBI | SPDR SERIES TRUST | 4,530 | $317 | 0.0% | $62.27 | — | S&P BIOTECH | 78464A870 |
| — | ADURO BIOTECH INC | 10,436 | $294 | 0.0% | $30.34 | — | COM | 00739L101 |
| — | DBV TECHNOLOGIES S A | 7,994 | $290 | 0.0% | $35.59 | — | SPONSORED ADR | 23306J101 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 24,236 | $231 | 0.0% | $22.17 | — | COM | 05337G107 |
| — | ACCELERATE DIAGNOSTICS INC | 10,000 | $215 | 0.0% | $21.50 | — | COM | 00430H102 |
| — | CASTLIGHT HEALTH INC | 10,229 | $44 | 0.0% | $12.24 | — | CL B | 14862Q100 |
| AUPH | AURINIA PHARMACEUTICALS INC | 16,610 | $41 | 0.0% | $2.72 | 0.0% | COM | 05156V102 |